MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Gamma Hydroxybutyric Acid.
Abiraterone
The serum concentration of Eszopiclone can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Aceprometazine.
Alfaxalone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Alfentanil.
Alphaprodine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Alprazolam.
Amiodarone
The metabolism of Eszopiclone can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amoxapine.
Apalutamide
The serum concentration of Eszopiclone can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Eszopiclone can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Aripiprazole.
Articaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Asenapine.
Atazanavir
The metabolism of Eszopiclone can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Eszopiclone can be decreased when combined with Atomoxetine.
Azelastine
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Benzyl alcohol.
Boceprevir
The metabolism of Eszopiclone can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Eszopiclone can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Eszopiclone can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Bromazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Bromazepam.
Bromperidol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Bupivacaine.
Buprenorphine
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Eszopiclone.
Butalbital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Butorphanol.
Capecitabine
The metabolism of Eszopiclone can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Eszopiclone can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Carisoprodol.
Celecoxib
The metabolism of Eszopiclone can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Eszopiclone can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlordiazepoxide.
Chlormethiazole
The risk or severity of adverse effects can be increased when Eszopiclone is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Eszopiclone can be decreased when combined with Cholecalciferol.
Citalopram
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Citalopram.
Clarithromycin
The metabolism of Eszopiclone can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Eszopiclone can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clobazam.
Clofezone
The metabolism of Eszopiclone can be decreased when combined with Rabeprazole.
Clomipramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Clorazepate.
Clotrimazole
The metabolism of Eszopiclone can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Eszopiclone.
Cobicistat
The metabolism of Eszopiclone can be decreased when combined with Cobicistat.
Cocaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Eszopiclone.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Eszopiclone.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Eszopiclone.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Eszopiclone.
Crisaborole
The metabolism of Eszopiclone can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Eszopiclone can be decreased when combined with Crizotinib.
Cyclizine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cyclobenzaprine.
Cyclosporine
The metabolism of Eszopiclone can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cyproheptadine.
Dabrafenib
The serum concentration of Eszopiclone can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dapiprazole.
Darunavir
The metabolism of Eszopiclone can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Eszopiclone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Eszopiclone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Eszopiclone can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Eszopiclone can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Desflurane.
Desipramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Eszopiclone is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dihydrocodeine.
Dihydroergotamine
The metabolism of Eszopiclone can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Eszopiclone can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Diphenoxylate.
Dothiepin
The metabolism of Eszopiclone can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Doxepin.
Doxycycline
The metabolism of Eszopiclone can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Eszopiclone can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Dronedarone
The metabolism of Eszopiclone can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Duloxetine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dyclonine.
Efavirenz
The metabolism of Eszopiclone can be decreased when combined with Efavirenz.
Enflurane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Entacapone.
Enzalutamide
The serum concentration of Eszopiclone can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Eszopiclone can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Estazolam.
Ethanol
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Etomidate.
Etravirine
The metabolism of Eszopiclone can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Felbamate.
Felodipine
The metabolism of Eszopiclone can be decreased when combined with Felodipine.
Fentanyl
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fentanyl.
Fexofenadine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flibanserin.
Floxuridine
The metabolism of Eszopiclone can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Eszopiclone can be decreased when combined with Fluconazole.
Flumazenil
Flumazenil may decrease the sedative activities of Eszopiclone.
Flunarizine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flunitrazepam.
Fluorouracil
The metabolism of Eszopiclone can be decreased when combined with Fluorouracil.
Fluoxetine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fluphenazine.
Flurazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Eszopiclone can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Eszopiclone can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Eszopiclone can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Eszopiclone can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Eszopiclone can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fospropofol.
Fusidate
The serum concentration of Eszopiclone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Eszopiclone can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Gabapentin Enacarbil.
Gemfibrozil
The metabolism of Eszopiclone can be decreased when combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Hexobarbital.
Hydrocodone
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Eszopiclone.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Hypoxis hemerocallidea root extract
The serum concentration of Eszopiclone can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Eszopiclone can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Iloperidone.
Imatinib
The metabolism of Eszopiclone can be decreased when combined with Imatinib.
Imipramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Imipramine.
Indinavir
The metabolism of Eszopiclone can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Eszopiclone can be decreased when combined with Indinavir.
Irbesartan
The metabolism of Eszopiclone can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Eszopiclone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Eszopiclone can be decreased when combined with Isavuconazonium.
Isoflurane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Isoflurane.
Isradipine
The metabolism of Eszopiclone can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Eszopiclone can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Eszopiclone can be increased when it is combined with Ivacaftor.
Ketamine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ketazolam.
Ketoconazole
The metabolism of Eszopiclone can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lamotrigine.
Lapatinib
The metabolism of Eszopiclone can be decreased when combined with Lapatinib.
Leflunomide
The metabolism of Eszopiclone can be decreased when combined with Leflunomide.
Levetiracetam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lidocaine.
Lithium
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lithium.
Lopinavir
The metabolism of Eszopiclone can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Eszopiclone.
Lormetazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lormetazepam.
Losartan
The metabolism of Eszopiclone can be decreased when combined with Losartan.
Lovastatin
The metabolism of Eszopiclone can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Loxapine.
Luliconazole
The serum concentration of Eszopiclone can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Eszopiclone can be increased when it is combined with Lumacaftor.
Lurasidone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Eszopiclone can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Eszopiclone can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Eszopiclone can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pethidine.
Mephobarbital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Eszopiclone.
Mesoridazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Eszopiclone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methohexital.
Methotrimeprazine
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methsuximide.
Metylperon
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Melperone.
Metyrosine
Eszopiclone may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Midazolam.
Midostaurin
The metabolism of Eszopiclone can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Eszopiclone can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Mirtazapine
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Eszopiclone can be decreased when it is combined with Mitotane.
Molindone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Eszopiclone.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Nalbuphine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Nalbuphine.
Nefazodone
The metabolism of Eszopiclone can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Eszopiclone can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Eszopiclone can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Eszopiclone can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Eszopiclone can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Eszopiclone can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Nitrous oxide.
Norflurane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Nortriptyline.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Eszopiclone.
Olaparib
The metabolism of Eszopiclone can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Olopatadine.
Omeprazole
The metabolism of Eszopiclone can be decreased when combined with Omeprazole.
Ondansetron
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Opium.
Orphenadrine
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Eszopiclone can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxazepam.
Oxprenolol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxymorphone.
Palbociclib
The serum concentration of Eszopiclone can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Paliperidone.
Paraldehyde
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Eszopiclone.
Paroxetine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pentazocine.
Pentobarbital
The metabolism of Eszopiclone can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Perazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Perphenazine.
Phenobarbital
The metabolism of Eszopiclone can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Phenoxyethanol.
Phenytoin
The metabolism of Eszopiclone can be increased when combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pimozide.
Pioglitazone
The metabolism of Eszopiclone can be decreased when combined with Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pomalidomide.
Posaconazole
The metabolism of Eszopiclone can be decreased when combined with Posaconazole.
Pramipexole
Eszopiclone may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Eszopiclone can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Prilocaine.
Primidone
The metabolism of Eszopiclone can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Prochlorperazine.
Promazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Protriptyline.
Pyrimethamine
The metabolism of Eszopiclone can be decreased when combined with Pyrimethamine.
Quazepam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Quetiapine.
Quinine
The metabolism of Eszopiclone can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Eszopiclone can be decreased when combined with Rabeprazole.
Ramelteon
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ramelteon.
Ranolazine
The metabolism of Eszopiclone can be decreased when combined with Ranolazine.
Remifentanil
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Eszopiclone.
Rifabutin
The metabolism of Eszopiclone can be increased when combined with Rifabutin.
Rifampin
The metabolism of Eszopiclone can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Eszopiclone can be increased when combined with Rifapentine.
Risperidone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Risperidone.
Ropinirole
Eszopiclone may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ropivacaine.
Rosiglitazone
The metabolism of Eszopiclone can be decreased when combined with Rosiglitazone.
Rotigotine
Eszopiclone may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Eszopiclone can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Eszopiclone.
Saquinavir
The metabolism of Eszopiclone can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Eszopiclone can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Eszopiclone can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Scopolamine.
Secobarbital
The metabolism of Eszopiclone can be increased when combined with Secobarbital.
Sertindole
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Sevoflurane.
Sildenafil
The metabolism of Eszopiclone can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Eszopiclone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Eszopiclone can be increased when it is combined with Simeprevir.
Sodium Oxybate
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Sorafenib
The metabolism of Eszopiclone can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Eszopiclone can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Sufentanil.
Sulfadiazine
The metabolism of Eszopiclone can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Eszopiclone can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Eszopiclone can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Sulpiride.
Suvorexant
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tamoxifen
The metabolism of Eszopiclone can be decreased when combined with Tamoxifen.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Tasimelteon
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tasimelteon.
Telaprevir
The metabolism of Eszopiclone can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Eszopiclone can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Eszopiclone.
Teriflunomide
The metabolism of Eszopiclone can be decreased when combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Thalidomide
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tiapride.
Ticagrelor
The metabolism of Eszopiclone can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Eszopiclone can be decreased when combined with Ticlopidine.
Tizanidine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tizanidine.
Tocilizumab
The serum concentration of Eszopiclone can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Eszopiclone can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tolcapone.
Topiramate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Topiramate.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Eszopiclone.
Tranylcypromine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Triflupromazine.
Trimethoprim
The metabolism of Eszopiclone can be decreased when combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Triprolidine.
Urethane
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Valproic Acid.
Valsartan
The metabolism of Eszopiclone can be decreased when combined with Valsartan.
Vemurafenib
The serum concentration of Eszopiclone can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Eszopiclone can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Eszopiclone can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Vigabatrin.
Voriconazole
The metabolism of Eszopiclone can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Vortioxetine.
Zafirlukast
The metabolism of Eszopiclone can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ziconotide.
Ziprasidone
The metabolism of Eszopiclone can be decreased when combined with Ziprasidone.
Zolpidem
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zuclopenthixol.
